Dr. John Hallgren
Claim this profileNovartis Investigative Site
Studies Cardiovascular Disease
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about John Hallgren
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments John Hallgren has experience with
- Pelacarsen (TQJ230)
Breakdown of trials John Hallgren has run
Cardiovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Hallgren specialize in?
John Hallgren focuses on Cardiovascular Disease and other conditions. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is John Hallgren currently recruiting for clinical trials?
No, John Hallgren is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that John Hallgren has studied deeply?
Yes, John Hallgren has studied treatments such as Pelacarsen (TQJ230).
What is the best way to schedule an appointment with John Hallgren?
Apply for one of the trials that John Hallgren is conducting.
What is the office address of John Hallgren?
The office of John Hallgren is located at: Novartis Investigative Site, Omaha, Nebraska 68114 United States. This is the address for their practice at the Novartis Investigative Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.